Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Cardiorenal Effects of Sotagliflozin Evaluated in T1D Patients
Teplizumab Gets Breakthrough Status for Type 1 Diabetes Prevention
Study Explores Dose Ranges for Efpeglenatide in Early T2DM
Mediterranean Eating Plan May Help Keep T2DM Patients Off Meds
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
FDA Approves Baqsimi Nasal Powder to Treat Severe Hypoglycemia
Mediterranean Diet May Reduce Gestational Diabetes Risk
FDA Approves Myxredlin, a Ready-to-Use Insulin for IV Infusion
Alirocumab Cuts CV Absolute Risk the Most for Those With Diabetes
FDA Rejects Dapagliflozin sNDA for Type 1 Diabetes
Solution Formulation of Levothyroxine Sodium Injection Now Available
FDA: Potential Cybersecurity Risks With Certain Insulin Pumps
Higher Intake of Linoleic Acid May Reduce Type 2 Diabetes Risk
Dulaglutide at Higher Doses Evaluated in Type 2 Diabetes Study
Somatuline Depot to Be Supplied in Redesigned Prefilled Syringe
Addition of GLP-1 Agonists, SGLT-2is May Benefit Patients on U-500 Insulin
Does the Use of DPP4-is in Combination With Statins Increase Myopathy Risk?
Avexitide Granted Breakthrough Tx Designation for Post-Bariatric Hypoglycemia
